Drugs / hepatitis B immunoglobulin
last change Apr 2013 re-read 2 minutes ago

hepatitis B immunoglobulin

also known as HBIG

Protein / enzyme biologic

Developed for
chronic hepatitis B virus infection

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT01412567 Comparator Oct 2005 → Jun 2010 chronic hepatitis B virus infection Govind Ballabh Pant Hospital Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as hepatitis B immunoglobulin “HBV vaccination with or without hepatitis B immunoglobulin (HBIG) prevents transmission of overt infection to the babies.” PMID 24168259 Apr 2013
Known as HBIG ClinicalTrials.gov intervention name — accepted as the source's own label NCT01412567
Modality Protein / enzyme biologic “hepatitis B immunoglobulin (HBIG)” NCT01412567
Route Intramuscular “0.5 mL intramuscularly immediately after birth” NCT01412567